Quantum-Si incorporated

NasdaqGM QSI

Quantum-Si incorporated Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2024: USD 21.00 K

Quantum-Si incorporated Net Cash Used Provided By Financing Activities is USD 21.00 K for the Trailing 12 Months (TTM) ending September 30, 2024, a -93.97% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.

Quantum-Si incorporated Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 348.00 K, a -88.38% change year over year.
Quantum-Si incorporated Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 3.00 M, a -99.45% change year over year.
Quantum-Si incorporated Net Cash Used Provided By Financing Activities for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 541.36 M.

Key data

Date	Net Cash Used Provided By Financing Activities	Dividends Paid	Capital Expenditure	Effect Of Forex Changes On Cash

NasdaqGM: QSI

Quantum-Si incorporated

CEO	Mr. Jeffrey Alan Hawkins
IPO Date	Nov. 13, 2020
Location	United States
Headquarters	530 Old Whitfield Street
Employees	159
Sector	Health Care
Industries Biotechnology Pharmaceuticals Semiconductors

Description

Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.

Key trends

Past 5 years